Aileen Lamb hopes the approval of a new cancer treatment drug will give patients 'hope', after she was given the all clear from acute myeloid leukaemia.
Aileen Lamb, from Edinburgh who had acute myeloid leukaemia said the approval of the new drug gives sufferers hope.
Axicabtagene ciloleucel, known by the brand name Yescarta, has been accepted for treating adults with two types of blood cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback